Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06055725 · ClinicalTrials.gov registry record
A Study to Estimate How Often Post-stroke Spasticity Occurs and to Provide a Standard Guideline on the Best Way to Monitor Its Development
A clinical trial of Spasticity as Sequela of Stroke, sponsored by Ipsen.
- Recruiting
- Registry status
- 1,051
- Enrollment target
- 20
- Study locations
NCT06055725 is a study of Spasticity as Sequela of Stroke that is actively recruiting participants, run by Ipsen. The registered enrollment target is 1,051 participants. The trial reports 20 study locations across 14 states.
The verdict
NCT06055725, a study of Spasticity as Sequela of Stroke, is actively recruiting participants, sponsored by Ipsen.
- RECRUITING
- Registry status
- 1,051 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study will monitor patients during the first year following their stroke. Stroke is a very serious condition where there is a sudden interruption of blood flow in the brain. The main aim of the study will be to find out how many of those who experience their first-ever stroke then go on to develop spasticity that would benefit from treatment with medication. Spasticity is a common post-stroke condition that causes stiff or ridged muscles. The results of this study will provide a standard guideline on the best way to monitor the development of post-stroke spasticity.
Conditions Studied
Study Locations (20)
Texas
- The University Of Texas Southwestern Medical Center - Dallas
- McGovern Medical School - UT Physicians - Neurology (Adult Neurology Clinic) - Texas Medical Center Location - Houston
- The University of Texas Health Science Center - San Antonio
California
- Loma Linda - Anderson
- University Of California, Los Angeles Medical Center - Los Angeles
Florida
- University of South Florida (USF) - Morsani Center (USF Health Carol and Frank Morsani Center for Advanced Healthcare) - Florida City
- Knight Neurology - Rockledge
Massachusetts
- Massachusetts General Hospital - Boston
- Spaulding Rehabilitation Hospital - Boston
Nebraska
- Methodist Physicians Clinic - Omaha
- Madonna Rehabilitation Hospital - Omaha Campus - Omaha
Georgia
- Emory University Merge - Atlanta
Maryland
- Medstar Health Research Institute, Inc - Hyattsville
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,051 participants |
| Start Date | 2023-11-01 |
| Est. Completion | 2027-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06055725
The ClinicalTrials.gov registry entry for NCT06055725 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,051 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ipsen, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Spasticity as Sequela of Stroke appearing as the primary indexed condition, and to 0 interventions.
NCT06055725 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Texas, California, Florida.
Frequently Asked Questions
What is clinical trial NCT06055725 about?
NCT06055725 is a clinical study titled "A Study to Estimate How Often Post-stroke Spasticity Occurs and to Provide a Standard Guideline on the Best Way to Monitor Its Development". This study will monitor patients during the first year following their stroke. Stroke is a very serious condition where there is a sudden interruption of blood flow in the brain. The main aim of the study will be to find out how many of those who experience their first-ever stroke then go on to de...
What is the current status of trial NCT06055725?
This trial is currently recruiting. The enrollment target is 1,051 participants. The study started on 2023-11-01. Estimated completion is 2027-11-30.
What conditions does trial NCT06055725 study?
This clinical trial studies the following conditions: Spasticity as Sequela of Stroke.
Who is sponsoring clinical trial NCT06055725?
This trial is sponsored by Ipsen, which has 85 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06055725 being conducted?
This trial has 20 study locations across California, Florida, Georgia, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spasticity as Sequela of Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.